27837917|t|Cocaine Use Reverses Striatal Plasticity Produced During Cocaine Seeking
27837917|a|Relapse is a two - component process consisting of a highly motivated drug-seeking phase that, if successful, is followed by a drug-using phase resulting in temporary satiation. In rodents, cue-induced drug seeking requires transient synaptic potentiation (t-SP) of cortical glutamatergic synapses on nucleus accumbens core medium spiny neurons, but it is unknown how achieving drug use affects this plasticity. We modeled the two phases of relapse after extinction from cocaine self-administration to assess how cocaine use affects t-SP associated with cue-induced drug seeking. Rats were trained to self-administer cocaine (n = 96) or were used as yoked - saline control animals (n = 21). After extinction, reinstatement was initiated by 10 minutes of cue-induced drug seeking, followed by 45 minutes with contingent cocaine access, after which cocaine was discontinued and unreinforced lever pressing ensued. Three measures of t-SP were assayed during reinstatement: dendritic spine morphology, alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) to N-methyl-D-aspartate (NMDA) ratios, and matrix metalloproteinase activity. We found that cocaine use for 10 minutes collapsed all three measures of cue-potentiated t-SP back to baseline. Moreover, when cocaine use was discontinued 45 minutes later, dendritic spine morphology and AMPA to NMDA ratios were restored as animals became motivated to engage unrewarded lever pressing. Nonreinforced drug seeking was positively correlated with changes in spine morphology, and cocaine access reversed this relationship. Using a novel modification of the reinstatement paradigm, we show that achieving cocaine use reversed the synaptic plasticity underpinning the motivation to seek the drug.
27837917	0	7	Cocaine	T109,T131	C0009170
27837917	8	11	Use	T169	C1524063
27837917	12	20	Reverses	T169	C1555029
27837917	21	40	Striatal Plasticity	T042	C0027880
27837917	41	49	Produced	T169	C0678227
27837917	50	56	During	T079	C0347984
27837917	57	64	Cocaine	T109,T131	C0009170
27837917	73	80	Relapse	T067	C0035020
27837917	86	89	two	T081	C0205448
27837917	92	101	component	T077	C1705248
27837917	102	109	process	T067	C1522240
27837917	126	132	highly	T080	C0205250
27837917	133	142	motivated	T041	C0026605
27837917	156	161	phase	T079	C0205390
27837917	186	197	followed by	T079	C0332283
27837917	200	210	drug-using	T048	C0242510
27837917	211	216	phase	T079	C0205390
27837917	217	229	resulting in	T169	C0332294
27837917	230	239	temporary	T079	C0205374
27837917	240	249	satiation	T041	C0036239
27837917	254	261	rodents	T015	C0035804
27837917	288	296	requires	T169	C1514873
27837917	297	328	transient synaptic potentiation	T042	C0206249
27837917	330	334	t-SP	T042	C0206249
27837917	339	370	cortical glutamatergic synapses	T030	C0039062
27837917	374	391	nucleus accumbens	T023	C0028633
27837917	392	396	core	T082	C0444669
27837917	397	417	medium spiny neurons	T025	C0682698
27837917	429	436	unknown	T080	C0439673
27837917	451	459	drug use	T048	C0242510
27837917	460	467	affects	T041	C0001721
27837917	473	483	plasticity	T042	C0027880
27837917	488	495	modeled	T077	C3714583
27837917	504	510	phases	T079	C0205390
27837917	514	521	relapse	T067	C0035020
27837917	528	538	extinction	T041	C0015347
27837917	544	551	cocaine	T109,T131	C0009170
27837917	552	571	self-administration	T061	C0036589
27837917	575	581	assess	T052	C1516048
27837917	586	593	cocaine	T109,T131	C0009170
27837917	598	605	affects	T041	C0001721
27837917	606	610	t-SP	T042	C0206249
27837917	611	626	associated with	T080	C0332281
27837917	653	657	Rats	T015	C0034721
27837917	674	689	self-administer	T061	C0036589
27837917	690	697	cocaine	T109,T131	C0009170
27837917	723	728	yoked	T073	C1710702
27837917	731	737	saline	T167	C0036082
27837917	738	753	control animals	T008	C1511501
27837917	770	780	extinction	T041	C0015347
27837917	782	795	reinstatement	T079	C0678335
27837917	800	809	initiated	T169	C1704686
27837917	816	823	minutes	T079	C0439232
27837917	853	864	followed by	T079	C0332283
27837917	868	875	minutes	T079	C0439232
27837917	881	891	contingent	T080	C1701901
27837917	892	899	cocaine	T109,T131	C0009170
27837917	900	906	access	T169	C1554204
27837917	920	927	cocaine	T109,T131	C0009170
27837917	932	944	discontinued	T033	C1444662
27837917	949	983	unreinforced lever pressing ensued	T033	C0243095
27837917	985	990	Three	T081	C0205449
27837917	991	999	measures	T081	C0079809
27837917	1003	1007	t-SP	T042	C0206249
27837917	1013	1020	assayed	T059	C1510438
27837917	1021	1027	during	T079	C0347984
27837917	1028	1041	reinstatement	T079	C0678335
27837917	1043	1058	dendritic spine	T026	C0872341
27837917	1059	1069	morphology	T080	C0332437
27837917	1071	1128	alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid	T109,T121,T130	C0051318
27837917	1130	1134	AMPA	T109,T121,T130	C0051318
27837917	1139	1159	N-methyl-D-aspartate	T116,T121,T123	C0079883
27837917	1161	1165	NMDA	T116,T121,T123	C0079883
27837917	1167	1173	ratios	T081	C0456603
27837917	1179	1203	matrix metalloproteinase	T116,T126	C0025543
27837917	1204	1212	activity	T044	C0243102
27837917	1217	1222	found	T033	C0243095
27837917	1228	1235	cocaine	T109,T131	C0009170
27837917	1247	1254	minutes	T079	C0439232
27837917	1255	1264	collapsed	T169	C0392748
27837917	1269	1274	three	T081	C0205449
27837917	1275	1283	measures	T081	C0079809
27837917	1303	1307	t-SP	T042	C0206249
27837917	1316	1324	baseline	T081	C1442488
27837917	1341	1348	cocaine	T109,T131	C0009170
27837917	1357	1369	discontinued	T033	C1444662
27837917	1373	1380	minutes	T079	C0439232
27837917	1388	1403	dendritic spine	T026	C0872341
27837917	1404	1414	morphology	T080	C0332437
27837917	1419	1423	AMPA	T109,T121,T130	C0051318
27837917	1427	1431	NMDA	T116,T121,T123	C0079883
27837917	1432	1438	ratios	T081	C0456603
27837917	1456	1463	animals	T008	C0003062
27837917	1471	1480	motivated	T041	C0026605
27837917	1502	1516	lever pressing	T033	C0243095
27837917	1549	1559	positively	T033	C1446409
27837917	1560	1570	correlated	T080	C1707520
27837917	1576	1583	changes	T169	C0392747
27837917	1587	1592	spine	T026	C2752558
27837917	1593	1603	morphology	T080	C0332437
27837917	1609	1616	cocaine	T109,T131	C0009170
27837917	1617	1623	access	T169	C1554204
27837917	1624	1632	reversed	T169	C1555029
27837917	1638	1650	relationship	T080	C0439849
27837917	1660	1665	novel	T080	C0205314
27837917	1666	1678	modification	T169	C0392747
27837917	1686	1699	reinstatement	T079	C0678335
27837917	1700	1708	paradigm	T062	C0681797
27837917	1733	1740	cocaine	T109,T131	C0009170
27837917	1745	1753	reversed	T169	C1555029
27837917	1758	1777	synaptic plasticity	T042	C1254358
27837917	1795	1805	motivation	T041	C0026605
27837917	1818	1822	drug	T121	C1254351